ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 824 filers reported holding ISHARES TR in Q3 2022. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,569 | -3.8% | 2,609 | 0.0% | 0.06% | -3.4% |
| Q2 2023 | $331,238 | -0.8% | 2,609 | +0.9% | 0.06% | -9.2% |
| Q1 2023 | $334,008 | -1.6% | 2,586 | 0.0% | 0.06% | -9.7% |
| Q4 2022 | $339,516 | -2.2% | 2,586 | -13.1% | 0.07% | -13.3% |
| Q3 2022 | $347,000 | -8.4% | 2,976 | -7.9% | 0.08% | -7.8% |
| Q2 2022 | $379,000 | -10.0% | 3,231 | 0.0% | 0.09% | +7.1% |
| Q1 2022 | $421,000 | -14.8% | 3,231 | 0.0% | 0.08% | -15.2% |
| Q4 2021 | $494,000 | -5.5% | 3,231 | 0.0% | 0.10% | -38.9% |
| Q3 2021 | $523,000 | +1.6% | 3,231 | +2.4% | 0.16% | +6.6% |
| Q2 2021 | $515,000 | -3.0% | 3,156 | -11.1% | 0.15% | -21.6% |
| Q1 2021 | $531,000 | -2.6% | 3,552 | -1.5% | 0.19% | -9.3% |
| Q4 2020 | $545,000 | +11.9% | 3,605 | 0.0% | 0.21% | -16.1% |
| Q3 2020 | $487,000 | -4.1% | 3,605 | -3.3% | 0.26% | -28.0% |
| Q2 2020 | $508,000 | +19.0% | 3,728 | -5.5% | 0.35% | -16.1% |
| Q1 2020 | $427,000 | -9.9% | 3,947 | +0.4% | 0.42% | +6.0% |
| Q4 2019 | $474,000 | – | 3,932 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |